Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.94 USD | +1.31% | +1.36% | -4.63% |
Chart calendar Bristol-Myers Squibb Company
Upcoming events on Bristol-Myers Squibb Company
Past events on Bristol-Myers Squibb Company
2024-04-07 01:45 pm | American College of Cardiology Scientific Meeting - Poster No 1075-09 |
2024-04-07 01:30 pm | American College of Cardiology Scientific Meeting - Poster No: 1075-07 |
2024-04-07 01:15 pm | American College of Cardiology Scientific Meeting - Abstract No: 1424-134 |
2024-04-07 12:00 pm | American College of Cardiology Scientific Meeting - Poster No: 1065-11 |
2024-04-06 02:45 pm | American College of Cardiology Scientific Meeting - Poster No: 1306-157 |
2024-04-06 01:45 pm | American College of Cardiology Scientific Meeting - Poster No: 1284-132 |
2024-04-06 11:45 am | American College of Cardiology Scientific Meeting - Poster No: 1244-128 |
2024-04-03 | Ex-dividend day |
2024-04-02 | Schizophrenia International Research Society Congress |
2024-03-14 | Federal Register Oncologic Drugs Advisory Committee Meeting |
2024-03-14 08:30 am | Barclays Global Healthcare Conference |
2024-03-13 10:00 am | Leerink Partners Global Biopharma Conference |
2024-03-04 09:50 am | TD Cowen Health Care Conference |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P35 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P35 |
2024-02-28 | Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09 |
Past dividends on Bristol-Myers Squibb Company
2024-04-03 | Quarterly 0.6 USD |
2024-01-03 | Quarterly 0.6 USD |
2023-10-04 | Quarterly 0.57 USD |
2023-07-05 | Quarterly 0.57 USD |
2023-04-05 | Quarterly 0.57 USD |
2023-01-04 | Quarterly 0.57 USD |
2022-10-05 | Quarterly 0.54 USD |
2022-06-29 | Quarterly 0.54 USD |
2022-03-30 | Quarterly 0.54 USD |
2022-01-05 | Quarterly 0.54 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 26 145 26 418 -1.03% | 42 518 42 189 0.78% | 46 385 46 366 0.04% | 46 159 45 911 0.54% | 45 006 44 731 0.62% | 45 827 |
EBITDA Million USD | Released Forecast Spread | 9 945 9 754 1.96% | 18 118 20 279 -10.65% | 20 493 21 878 -6.33% | 20 123 20 368 -1.2% | 17 498 18 255 -4.15% | 4 607 |
EBIT Million USD | Released Forecast Spread | 8 199 8 540 -3.99% | 17 426 17 664 -1.35% | 19 830 19 963 -0.67% | 19 442 18 924 2.73% | 16 785 16 921 -0.8% | 3 979 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 975 0,00 - | -6 871 1 541 -545.88% | 8 098 7 644 5.94% | 7 713 7 912 -2.51% | 8 440 8 846 -4.59% | -18 524 |
Net income Million USD | Released Forecast Spread | 3 439 0,00 - | -9 015 1 269 -810.58% | 6 994 6 219 12.46% | 6 327 6 617 -4.39% | 8 025 7 823 2.58% | -3 954 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | -3,99 0,53 -851.84% | 3,12 2,78 12.07% | 2,95 2,97 -0.55% | 3,86 3,73 3.53% | -1,45 |
Announcement Date | 06/02/20 | 04/02/21 | 04/02/22 | 02/02/23 | 02/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 985 11 998 -0.11% | 11 648 11 343 2.69% | 11 887 11 467 3.66% | 11 218 11 180 0.34% | 11 406 11 198 1.86% | 11 337 11 498 -1.4% | 11 226 11 811 -4.95% | 10 966 10 959 0.06% | 11 477 11 203 2.45% | 11 454 | 11 521 | 11 274 | 11 730 | 11 694 |
EBITDA Million USD | Released Forecast Spread | 4 832 5 087 -5.01% | 5 305 5 176 2.5% | 7 812 5 060 54.38% | 7 424 4 973 49.29% | 4 288 4 594 -6.66% | 5 030 4 732 6.3% | 4 268 6 031 -29.24% | 4 539 5 339 -14.98% | 3 816 4 833 -21.04% | -8 519 | 4 549 | 4 218 | 4 368 | |
EBIT Million USD | Released Forecast Spread | 4 670 4 823 -3.17% | 5 267 4 848 8.63% | 5 229 4 563 14.58% | 4 836 4 622 4.62% | 4 110 4 248 -3.26% | 4 857 4 816 0.85% | 4 251 4 785 -11.16% | 4 360 4 206 3.66% | 3 630 3 663 -0.91% | -8 507 | 4 268 | 4 186 | 4 220 | 4 957 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 958 2 118 -7.55% | 2 209 2 139 3.27% | 1 859 1 767 5.21% | 2 770 2 808 -1.34% | 1 859 2 836 -34.44% | 2 137 2 216 -3.58% | 1 674 2 000 -16.28% | 2 302 | 2 226 | 2 268 | ||||
Net income Million USD | Released Forecast Spread | 2 372 1 419 67.16% | 1 278 | 1 421 1 423 -0.11% | 1 606 1 469 9.33% | 2 022 1 444 40.03% | 2 262 2 290 -1.24% | 2 073 2 165 -4.23% | 1 928 1 585 21.63% | 1 762 1 479 19.13% | -9 816 | 1 860 | 1 761 | 1 953 | |
EPS USD | Released Forecast Spread | 1,07 0,96 11.85% | 0,59 0,86 -31.4% | 0,66 0,58 13.79% | 0,75 0,71 5.63% | 0,95 0,73 31.03% | 1,07 1,19 -10.08% | 0,99 1,16 -14.88% | 0,93 0,89 4.03% | 0,87 0,72 20.52% | -4,68 | 1,03 | 0,98 | 1,06 | 1,83 |
Announcement Date | 04/02/22 | 29/04/22 | 27/07/22 | 25/10/22 | 02/02/23 | 27/04/23 | 27/07/23 | 26/10/23 | 02/02/24 | - | - | - | - | - |
Past sector events for Bristol-Myers Squibb Company
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BMY Stock
- Calendar Bristol-Myers Squibb Company